Magda Marquet, Ph.D.

Magda Marquet, Ph.D.

medical skin treatment product specialistsDr. Magda Marquet is the founder and co-Chair of Ajinomoto Althea Technologies, and served as its co-President and CEO for ten years. Dr. Marquet is also founder and co-Chair of Althea Dx, a spin-off of Althea Technologies focusing in companion diagnostics development. She is the Chairwoman of BIOCOM and she is on the Board of UCSD Moores Cancer Center. She is currently involved as investor, adviser, and board member in over twenty local San Diego companies. Dr. Marquet has over twenty-five years of experience in the biotechnology industry in the United States and Europe. She was formerly Executive Director of Pharmaceutical Development at Vical Incorporated, where she patented several novel methods for the production of clinical grade DNA for use in gene therapy and DNA vaccines. Prior to joining Vical, Dr. Marquet held management positions at Amylin Pharmaceuticals, Protein Polymer Technologies, Syntro Corporation and Transgene. Dr. Marquet holds a Ph.D. in Biochemical Engineering from INSA/University of Toulouse, France. Dr. Marquet was the winner of the 2005 Regional Ernst & Young Entrepreneur of the Year award in the Life Sciences category.

Next, read about Philippe Schaison.